ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,483.66
0.19%
US Tech 100
19,394.80
-0.04%
다우존스 지수
38,792.13
0.04%
Bitcoin
64,526.47
-2.95%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Dianthus Therapeutics Inc (DNTH)

  7. Dianthus Therapeutics Inc (DNTH) 뉴스

DNTH

Dianthus Therapeutics (DNTH)

Dianthus Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:DNTH
일자시간출처헤드라인심볼기업
2024/06/1220:00GlobeNewswire Inc.Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)NASDAQ:DNTHDianthus Therapeutics Inc
2024/05/3105:30GlobeNewswire Inc.Dianthus Therapeutics to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:DNTHDianthus Therapeutics Inc
2024/05/1005:01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
2024/05/0905:30GlobeNewswire Inc.Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care ConferenceNASDAQ:DNTHDianthus Therapeutics Inc
2024/05/0405:30GlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
2024/04/1120:30GlobeNewswire Inc.Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual MeetingNASDAQ:DNTHDianthus Therapeutics Inc
2024/04/0605:30GlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
2024/03/2205:01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
2024/03/0806:30GlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
2024/02/2621:00GlobeNewswire Inc.Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG)NASDAQ:DNTHDianthus Therapeutics Inc
 검색 관련기사 보기:NASDAQ:DNTH

최근 히스토리

LSE
SY38
Citi Fun 27
COIN
ZENFETH
ZENF Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유